Research Highlights People with schizophrenia die 15–20 years earlier on average (SMR 2.5–3.5x), develop dementia roughly 20 years earlier, and show metabolic disease in their 20s and 30s. The 2008 “accelerated aging” hypothesis was coined to explain that pattern.1,6,7 A 2026 systematic review of 170 studies argues “advanced aging” fits better than “accelerated aging,” with …
Research Highlights Across 65 studies and 31,495 lupus patients, 4.5% develop psychosis (95% CI 3.6–5.5%). Among patients with neuropsychiatric lupus (NPSLE), the rate jumps to 20.5% (95% CI 10.0–37.6%).1 The 4.5% figure is roughly 50 to 100 times higher than the lifetime prevalence of primary psychotic disorders in age-matched general population samples. Psychosis usually shows …
A 1.6M-participant meta-analysis shows a clear gradient: parental schizophrenia hits offspring cognition harder than bipolar, which hits harder than MDD.
AVATAR therapy ties CBT at end of treatment, edges ahead at 3-month follow-up, and uses half the sessions. The ‘better than CBT’ framing outpaces the formal statistics.
The intricate dance between parasites, mental health, and stress hormones is a subject of growing scientific inquiry, offering fascinating insights into how microscopic organisms might influence human behavior and psychiatric conditions. A recent study delves into the relationship between Toxoplasma gondii (TG), a common protozoan parasite, and its potential impact on individuals with schizophrenia, focusing …
Schizophrenia (SCZ) is a complex psychiatric disorder that affects millions worldwide, with symptoms ranging from hallucinations to disorganized thinking. Research into the causative factors of SCZ has expanded into the realm of immunology, examining how immune system interactions with the brain might influence the development and progression of the disorder. A recent comprehensive study using …
Attention Deficit Hyperactivity Disorder (ADHD) is a complex neurodevelopmental condition that significantly impacts individuals’ lives. Recent advancements in genetic research, particularly Mendelian Randomization (MR) studies, have begun to unravel the intricate genetic associations between ADHD and other psychiatric disorders, offering new insights into their comorbidities. By leveraging data from genome-wide association studies (GWAS), this research …